CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY

临床试验：在中断治疗的 HIV-1 受试者中使用 MRK AD5 HIV-1 GAG 疫苗

• 批准号: 7716792
• 负责人: DAVID A WOHL
• 金额: $ 1.34万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716792
• 关键词: Anti-HIV Agents; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Gagging; Grant; HIV; HIV vaccine; Institution; Placebos; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Vaccines; Viral Load result

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will compare the HIV viral load of people off anti-HIV drugs who have either received an HIV-vaccine or a vaccine placebo.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究将比较服用抗HIV药物的人的HIV病毒载量，这些人接受了HIV疫苗或疫苗安慰剂。